Artificial intelligence may be advancing rapidly through hospitals and clinics, but public acceptance of the technology is not guaranteed, according to a qualitative study of consumer perspectives published in JAMA Network Open. The research suggests that “social license” for health care AI is not a permanent approval granted once and retained indefinitely. Instead, it is conditional, dynamic, and continually reshaped by how systems are designed, how they perform, and how patients and clinicians experience them in practice.
The concept of social license describes the informal level of public acceptance that allows an emerging technology or organization to operate with society’s approval, even when that approval is not established through laws or formal regulations. In the context of artificial intelligence, social license can determine whether patients are willing to accept algorithm-assisted diagnoses, automated administrative systems, predictive tools, or AI-supported clinical decision-making. The study indicates that acceptance depends on more than whether an algorithm is technically accurate. It also depends on whether people believe the technology fits within the values and relationships that define good health care.
The researchers found that structural factors form one of the central foundations of public trust. These factors include the policies, governance systems, institutional safeguards, and accountability mechanisms surrounding an AI tool. Patients may ask who developed the system, what data were used to train it, how personal information is protected, and who is responsible if the system makes a harmful recommendation. Such questions are especially important because modern AI systems can process vast volumes of medical records, imaging data, laboratory results, and other sensitive information, often through complex computational models that are difficult for non-specialists to interpret.
Performance factors also strongly influence whether consumers continue to support AI in clinical settings. An AI system may be designed to recognize patterns in medical images, estimate a patient’s risk of developing a disease, or help clinicians identify the most appropriate treatment. However, technical performance measured in a laboratory or validation study may not fully predict how the system works in real-world care. Accuracy, reliability, consistency, transparency, and the ability to perform across different patient populations all contribute to public confidence. A tool that performs well for one demographic group but produces less reliable results for another could quickly undermine trust and raise concerns about algorithmic bias.
The study further emphasizes that technical capability alone cannot replace human judgment. Health care decisions frequently involve uncertainty, personal priorities, cultural context, and emotional distress—factors that may not be captured in structured data. Consumers appear to expect AI to support clinicians rather than remove the human relationship from care. This distinction is crucial: an algorithm may identify a potential diagnosis or flag a concerning trend, but patients may still want a qualified professional to explain the result, discuss alternatives, respond to questions, and understand the circumstances that make each person’s situation unique.
Relational factors therefore emerged as another important component of social license. These factors concern the relationships among patients, clinicians, health care institutions, and the developers of AI systems. Patients may be more willing to accept AI when clinicians remain visibly involved and can explain how a tool contributed to a decision. Conversely, acceptance may weaken if people feel that an automated system is being used to replace meaningful communication or to accelerate appointments at the expense of empathy. The findings suggest that AI implementation is not simply a technical upgrade; it is also a change to the social and emotional structure of medical care.
Because social license is dynamic, public acceptance can shift as people encounter AI in different circumstances. A system that is welcomed for reducing paperwork may be viewed differently when it influences a diagnosis or treatment recommendation. Similarly, a positive initial experience could be reversed by a privacy breach, an unexplained error, or evidence that a tool performs unevenly across communities. This means health care organizations may need to monitor trust continuously rather than treating public consultation as a one-time stage completed before deployment.
The study provides evidence-based recommendations for stakeholders designing and implementing clinical AI. Developers are encouraged to build tools around the needs of both consumers and clinicians, with clear explanations of what the system does, what its limitations are, and when its recommendations should be questioned. Health care organizations may need strong oversight procedures, transparent evaluation, mechanisms for reporting errors, and clear lines of responsibility. Clinicians, meanwhile, will require training that covers not only how to use AI systems but also how to communicate their role to patients and recognize situations in which automated outputs may be unreliable.
The researchers argue that the most socially acceptable AI will be technology that strengthens personalized, empathetic, and responsive care. This could include systems that help clinicians spend less time on repetitive documentation and more time speaking with patients, provided that efficiency gains do not become a justification for reducing human contact. The public’s willingness to accept AI may ultimately depend on whether it is experienced as an instrument for better care or as a barrier between patients and the professionals they trust.
The findings arrive as health systems worldwide explore increasingly sophisticated forms of artificial intelligence, from machine-learning models that analyze medical images to generative systems capable of summarizing records and producing clinical text. The study suggests that the future of health care AI will be shaped not only by computing power or benchmark scores but also by sustained public judgment. Social license will have to be earned repeatedly through responsible governance, dependable performance, open communication, and visible respect for the human relationships at the center of medicine.
Subject of Research: Consumer perspectives on artificial intelligence in health care and the conditions shaping public acceptance, or “social license,” for clinical AI.
News Publication Date: Not provided.
Web References: https://doi.org/10.1001/jamanetworkopen.2026.26916
References: Duong T et al. Qualitative study of consumer perspectives on AI in health care. JAMA Network Open. DOI: 10.1001/jamanetworkopen.2026.26916.
Keywords: Artificial intelligence, health care, clinical AI, social license, patient trust, algorithmic bias, digital health, health care delivery, machine learning, patient-centered care
